In recent years, there has been a proliferation of new terms in relation to malaria in scientific literature, technical reports and the media. Concurrently, a number of terms with new or modified use and meaning have been introduced. This glossary of malaria terminology, updated in 2021, is based on input from WHO technical expert groups and aims to improve communication and mutual understanding within the scientific community, as well as with funding agencies, public health officials responsible for malaria programmes, and policymakers in malaria endemic countries.
This document provides extended guidance to countries that are nearing malaria elimination on preparing for certification. It includes an overview of the certification process and examines the activities required in national preparation for certification. It provides tools that countries can use to organize the documentation required for certification, to prepare a national elimination report and to assess their readiness for certification. Guidance on verification of subnational malaria elimination, a process overseen by national authorities, is also provided. This second edition clarifies the definition of human infections of Plasmodium knowlesi and its implications to certification and includes the template for national elimination report in Annex 4.
This document is intended as a guide for studies of chemoprevention efficacy and was developed based on reviews of protocols of ongoing studies. The document adapts some of the principles and practices underlying treatment efficacy monitoring to provide standardized approaches for monitoring and evaluating the efficacy of medicines used for malaria chemoprevention. This guide will be updated once additional experience is gained from studies of chemoprevention efficacy.
The meeting objectives included providing an overview of the current status of insecticide resistance and resistance management practices, as well as of the ways in which economic principles can be applied to value insecticide susceptibility. The main target audiences were National Malaria Control Programs, their implementing partner organizations and donors.
Indoor residual spraying (IRS) involves applying residual insecticide to potential vector resting sites on the interior surfaces of human dwellings or other buildings. The main aim of IRS is to kill vectors before they are able to transmit pathogens to humans. When carried out correctly, IRS has historically been shown to be a powerful intervention to reduce adult vector density and longevity for mosquitoes, sand flies and triatomine bugs and can reduce the transmission of vector-borne diseases. This operational manual is designed to provide guidance on the establishment, management, implementation, reporting and evaluation of safe and effective IRS campaigns within the context of a locally adapted and sustainable vector control programme, in line with the Global vector control response 2017–2030. It provides information according to current WHO recommendations and standards on IRS and recognizes that IRS can potentially target multiple diseases in areas where endophilic vectors coexist. The key audience for this document is vector-borne disease control programme managers and staff, as well as implementing or private-sector partners at the national, provincial/state or local levels, who are responsible for the design, planning or implementation of vector control operations.
THE ESSENTIAL WORK IN TRAVEL MEDICINE -- NOW COMPLETELY UPDATED FOR 2018 As unprecedented numbers of travelers cross international borders each day, the need for up-to-date, practical information about the health challenges posed by travel has never been greater. For both international travelers and the health professionals who care for them, the CDC Yellow Book 2018: Health Information for International Travel is the definitive guide to staying safe and healthy anywhere in the world. The fully revised and updated 2018 edition codifies the U.S. government's most current health guidelines and information for international travelers, including pretravel vaccine recommendations, destination-specific health advice, and easy-to-reference maps, tables, and charts. The 2018 Yellow Book also addresses the needs of specific types of travelers, with dedicated sections on: · Precautions for pregnant travelers, immunocompromised travelers, and travelers with disabilities · Special considerations for newly arrived adoptees, immigrants, and refugees · Practical tips for last-minute or resource-limited travelers · Advice for air crews, humanitarian workers, missionaries, and others who provide care and support overseas Authored by a team of the world's most esteemed travel medicine experts, the Yellow Book is an essential resource for travelers -- and the clinicians overseeing their care -- at home and abroad.
Psychological Crisis Intervention: The SAFER-R Model is designed to provide the reader with a simple set of guidelines for the provision of psychological first aid (PFA). The model of psychological first aid (PFA) for individuals presented in this volume is the SAFER-R model developed by the authors. Arguably it is the most widely used tactical model of crisis intervention in the world with roughly 1 million individuals trained in its operational and derivative guidelines. This model of PFA is not a therapy model nor a substitute for therapy. Rather it is designed to help crisis interventionists stabile and mitigate acute crisis reactions in individuals, as opposed to groups. Guidelines for triage and referrals are also provided. Before plunging into the step-by-step guidelines, a brief history and terminological framework is provided. Lastly, recommendations for addressing specific psychological challenges (suicidal ideation, resistance to seeking professional psychological support, and depression) are provided.
Infectious diseases are the leading cause of death globally, particularly among children and young adults. The spread of new pathogens and the threat of antimicrobial resistance pose particular challenges in combating these diseases. Major Infectious Diseases identifies feasible, cost-effective packages of interventions and strategies across delivery platforms to prevent and treat HIV/AIDS, other sexually transmitted infections, tuberculosis, malaria, adult febrile illness, viral hepatitis, and neglected tropical diseases. The volume emphasizes the need to effectively address emerging antimicrobial resistance, strengthen health systems, and increase access to care. The attainable goals are to reduce incidence, develop innovative approaches, and optimize existing tools in resource-constrained settings.
Preferred product characteristics" (PPCs) are key tools to incentivize and guide the development of urgently needed health products. This PPC was developed to indicate that WHO has identified vector control products targeting outdoor malaria transmission as an unmet public health need and to outline the preferred characteristics of such interventions. While keeping the scope of the PPC as broad as possible, it is primarily tailored to encourage new insecticidal/repellent products. Endectocides/ ectocides, as well as genetically modified mosquitoes, both of which could be considered to fall into the category of interventions targeting/contributing to the reduction of outdoor malaria transmission, are already covered by a separate PPC or warrant the development of one.
